|
Session 110
Poster Abstracts
HIV Integrase: Natural Variation and Resistance to Inhibitors
Wednesday, 1 - 4 pm
Poster Hall |
| 623 |
Natural Variation of HIV-1 Group M Integrase: Implications for Integrase Inhibitor Therapy
R Zioni*, S Rhee, T Liu, and R Shafer
Stanford Univ, CA, US |
| 624 |
Genetic Diversity of Integrase in HIV-1 Subtypes B, F, and C, Prevalent in Brazil: Study in Drug-naive and Multi-drug-resistant Individuals Reveals Impact for Drug Resistance
Caroline Passaes*, M Guimarães, R Lorete, J Fernandez, and M Morgado
Oswaldo Cruz Fndn, Rio de Janeiro, Brazil |
| 625 |
Frequency of Naturally Occuring Polymorphisms Associated with Resistance to Integrase Inhibitors in a Recently Infected Cohort
Andrea Low*1,2, Andrea Low*1,2, H Mohri1, M Markowitz1,2, and M Markowitz1,2
1Aaron Diamond AIDS Res Ctr, The Rockefeller Univ, New York, NY, US and 2The Rockefeller Univ, New York, NY, US |
626
 |
Polymorphism of HIV-1 Subtypes B and Non-B Integrase Gene
sabine yerly*, B hirschel, C gaille, L kaiser, and L perrin
Univ Hosp Geneva, Switzerland |
| 627 |
Resistance Profile of HIV-1 Mutants in vitro Selected by the HIV-1 Integrase Inhibitor, GS-9137 (JTK-303)
G Jones, R Ledford, F Yu, M Miller, M Tsiang, and Damian McColl*
Gilead Sci, Foster City, CA, US |
|
